CDSCO cracks down on pharma’s illegal detour

The Central Drugs Standard Control Organisation (CDSCO) is intensifying efforts to curb the illegal diversion of pharmaceutical drugs containing narcotic drugs and psychotropic substances, following a recent meeting focused on addressing regulatory gaps in drug control. This initiative stems from the 10th apex level National Committee for Coordination on Drug Trafficking (NCORD) meeting, chaired by Union Home Minister Amit Shah, which tasked the CDSCO with identifying and rectifying regulatory gaps to control drug diversion by March 2027.

The CDSCO has been assigned a pivotal role in preventing the diversion of these pharmaceutical drugs and was recently placed before the drugs consultative committee (DCC) to evaluate the existing regulatory framework for potential improvements. The DCC's recommendations are expected to inform an action plan aimed at strengthening the regulatory mechanism.

The CDSCO's efforts are part of a broader government strategy to enhance the country's response to evolving drug trafficking patterns, which now involve sophisticated methods such as encrypted communications, darknet platforms, cryptocurrencies, synthetic drugs, and even drones.

Brief written by urgent.news from The Economic Times's own syndicated text. Machine-written — may contain errors; check the original before relying on it.